Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Recipharm doubles EBIT and expects second quarter results to be stronger than analyst consensus

Net sales in the second quarter increased 65 per cent compared to the second quarter 2019, to SEK 3,081 million. Adjusted for currency and acquisitions organic growth was 12 per cent. EBITDA[1] for the quarter increased 70 per cent to SEK 600 million corresponding to an EBITDA margin[1] of 19 per cent.  EBITA[1] increased 83 per cent to SEK 423 million corresponding to a margin of 14 per cent. The organic increase in EBITA[1] was 34 per cent. EBIT increased 99 per cent to SEK 340 million. “During the quarter we managed to successfully mitigate operational challenges from lockdowns and

Result of incentive program in Initiator Pharma A/S

The warrant program 2020/2022, comprising a maximum of 434,197 warrants as resolved at the Annual General Meeting of 22 May 2020, has been fully subscribed. Subscription of warrants have been submitted by employees, board members and key consultants according to Appendix 2 to the AGM protocol from 22 May, 2020. The warrants are transferred to participants at a price of SEK 1.33 per warrant, equivalent to the market value according to an external independent valuation, applying the Black & Scholes model. The warrants are subject to vesting conditions described in Appendix 4k of the AGM

Alfa Laval takes the next step towards Industry 4.0 with AFRY

Alfa Laval – a world leader in heat transfer, centrifugal separation and fluid handling – will use advanced digital twin technology when expanding capacity in the production of separators in Sweden. The technology supplied by AFRY will facilitate the operations development and reduce the time for ramp-up of the production substantially.Alfa Laval will expand and automate its capacity in the production facility in Eskilstuna, Sweden. To facilitate the operations development the company will use Real Digital Twin (RDT) technology from AFRY. The technology, based on Siemens software, produces

NOTE’s Interim Report January–June 2020

Financial performance April–June• Sales increased by 14% to SEK 500 (437) million.• Operating profit was up by 36% to SEK 42 (31) million.• Operating margin widened by 1.3 percentage points to 8.3% (7.0%).• Profit after net financial items increased to SEK 42 (29) million.• Profit after tax increased by 44% to SEK 34 (23) million, corresponding to SEK 1.20 (0.84) per share.• Cash flow after investments amounted to SEK 64 (-24) million, or SEK 2.26 (-0.85) per share. Financial performance January–June• Sales increased by 16% to SEK 975 (843) million.• Operating profit was

Data presented at ISTH2020 strengthens evidence for both Elocta ® and Alprolix ® in previously untreated patients with haemophilia

Final results from the PUPs A-LONG and PUPs B-LONG studies assessing the efficacy and safety of Elocta® (efmoroctocog alfa) and Alprolix® (eftrenonacog alfa) in previously untreated patients (PUPs) with haemophilia A and B respectively were presented at the ISTH2020 (International Society on Thrombosis and Haemostasis) Virtual Congress, July 12-14. The results were presented jointly by Sobi™  and Sanofi, collaborators in the development and commercialisation of Alprolix and Elocta/ELOCTATE. “These are the first published final results for extended half-life (EHL)

Alfa Laval takes the next step towards Industry 4.0 through digital operations development

Alfa Laval – a world leader in heat transfer, centrifugal separation and fluid handling – will use advanced digital twin technology when expanding capacity in the production of separators in Sweden. The technology will facilitate the operations development and reduce the time for ramp-up of the production substantially.Alfa Laval will expand and automate its capacity in the production facility in Eskilstuna, Sweden. To facilitate the operations development the company will use Real Digital Twin (RDT) technology from AFRY, an international engineering, design and advisory company. The

Relais Group Plc: Certain shareholders have agreed to amend the terms of the Shareholders' Agreement

RELAIS GROUP PLC, COMPANY RELEASE July 13, 2020, AT 9.15 A.M. EETRelais Group Plc has been informed by its major shareholders Ari Salmivuori, Ajanta Oy and Nordic Industry Development AB, that these major shareholders have agreed to amend the terms of the shareholders' agreement between the aforementioned parties, the company and certain other shareholders of the company. The shareholders' agreement includes a call option in favor of Ari Salmivuori and Ajanta Oy with respect to certain shares of the company owned by Nordic Industry Development AB.  Ari Salmivuori's and Ajanta Oy's right to

Aker Solutions ASA: Improved Financial Results in the Second Quarter

July 13, 2020 - Aker Solutions’ second quarter of 2020 developed positively compared to expectations earlier this year when the COVID-19 pandemic started.This has resulted in significant improvement of revenue, earnings and order intake in the quarter, due to faster-than-expected implementation of cost-saving measures, higher activity than first anticipated on existing projects and several new contract awards. In the second quarter, the company expects operating revenue of about NOK 5.4 billion and EBITDA of about NOK 230 million. Excluding special items, EBITDA is expected to be about

Interim report January – June 2020: Extensive impact of covid-19

Second quarter · Sales amounted to SEK 209 (381) million, corresponding to a decrease of 45 percent in SEK. Sales decreased by 45 percent in local currency. Sales were negatively impacted by a decrease in demand due to covid-19. Demand was significantly higher at the end of the quarter compared to the beginning of the quarter. · Operating income before depreciation and amortisation (EBITDA) amounted to SEK 40 (146) million, corresponding to a margin of 19 (38) percent. Fluctuations in exchange rates negatively impacted EBITDA by SEK 4 million. · Net income amounted to SEK 12 (95)

Investor Report

RBC Covered Bond Programme Monthly Investor ReportCalculation Date:                          5/29/2020     This report containsinformation regardingassets pledged assecurity (the Cover Pool)in respect of theobligations under theCovered Bonds issuedunder RBC's GlobalCovered Bond Programme asof the indicatedCalculation Date. Thecomposition of the CoverPool will change as Loansare added and removedfrom the Cover Pool fromtime to time and,accordingly, thecharacteristics andperformance of the Loansin the Cover Pool willvary over time. Certainof

Alfa Laval announces a recommended public cash tender offer for all shares in Neles

Neles Corporation, Insider Information, July 13, 2020 at 8:30 am EESTTHIS STOCK EXCHANGE RELEASE MAY NOT BE RELEASED, PUBLISHED OR OTHERWISE DISTRIBUTED, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO AUSTRALIA, CANADA, HONG KONG SPECIAL ADMINISTRATIVE REGION OF THE PEOPLE’S REPUBLIC OF CHINA, JAPAN, NEW ZEALAND, SOUTH AFRICA, OR ANY OTHER JURISDICTION IN WHICH THE TENDER OFFER WOULD BE PROHIBITED BY APPLICABLE LAW. FOR FURTHER INFORMATION, PLEASE SEE SECTION ENTITLED “IMPORTANT INFORMATION” BELOW. Alfa Laval AB (publ) ("Alfa Laval" or the "Offeror"), a Swedish public limited

Several bright spots and lower losses

DNB's profits for the second quarter of 2020 were NOK 5 019 million, a decrease of NOK 1 115 million from the second quarter of 2019. The result is nonetheless significantly better than that of this year's first quarter, and the economic outlook is now less uncertain. After a very demanding start to the year, we are again seeing some bright spots for the Norwegian economy. The level of activity is higher, and this has affected DNB's results for the second quarter. “The situation is still challenging for many, not least for people who have been temporarily laid off and for businesses

Interim report January – June 2020

JANUARY – JUNE 2020 · Income MSEK 923 (656) · Profit after tax, MSEK 908 (470) · Profit after tax per share, SEK 5.07 (2.80) APRIL – JUNE 2020 · Income MSEK 493 (333) · Profit after tax, MSEK 249 (309) · Profit after tax per share, SEK 1.35 (1.84) SIGNIFICANT EVENTS DURING AND AFTER THE QUARTER · Acquisition of a property portfolio for a value of SEK 4.9 billion in June, 79 percent of the rental income from which is tax funded, and divestment of a project property in Gothenburg at a value of MSEK 400. · Divestment of a retail property in central Linköping

Alfa Laval announces a recommended public cash tender offer for all shares in Neles

Alfa Laval AB (publ) ("Alfa Laval" or the "Offeror"), a Swedish public limited liability company, and Neles Corporation ("Neles" or the "Company") have on 13 July 2020 entered into a combination agreement (the "Combination Agreement") pursuant to which Alfa Laval will make a voluntary recommended public cash tender offer for all issued and outstanding shares in Neles that are not held by Neles or any of its subsidiaries (the "Tender Offer"). In the Tender Offer, Neles’ shareholders will be offered a cash consideration of EUR 11.50 for each issued and outstanding share in Neles (the "Offer

Multiconsult nominated for significant contract on the new hospital at Gaustad (nye Rikshospitalet)

Helse Sør-Øst RHF has nominated Multiconsult for the design contract (phase 1) for the new hospital at Gaustad (nye Rikshospitalet) in Oslo. The contract involves the pre-design and includes all disciplines in the line of work, including an option for the detailed planning and construction phase.Multiconsult's fully owned subsidiary LINK arkitektur, as well as Fabel Arkitekter, Bølgeblikk arkitekter and Erichsen & Horgen AS are subcontractors. The new hospital at Gaustad (nye Rikshospitalet) will consist of approximately 140.000m2. The hospital will include regional and national

Half-year Report 2020

JANUARY 1 – JUNE 30, 2020(compared with the corresponding period a year ago) · Net sales declined 1.0% to SEK 62,119m (62,724) · Organic net sales declined 0.9% · Essity has increased market shares in many markets and increased online sales · Sales were negatively impacted by the COVID-19 pandemic and related lockdowns · In emerging markets, which accounted for 36% of net sales, organic net sales increased 2.3% · Operating profit before amortization of acquisition-related intangible assets (EBITA) increased 43% to SEK 9,159m (6,412) · Adjusted EBITA increased 32% to

Volati’s results better than expected

Volati announces that the Group’s results for Q2 2020 are better than it believes the market is expecting. According to preliminary figures for Q2, the Group’s net sales increased by 6 percent to SEK 1,889 (1,776) million and EBITA increased by 41 percent to SEK 181 (129) million compared with the same quarter the previous year. For the first six months, EBITA increased by 46 percent to SEK 243 (166) million compared with the same period the previous year.  “Volati has continued to develop positively in the second quarter with very strong earnings growth. Since the IPO in 2016, we have

Orkla ASA: Strong growth for Orkla’s brands

Orkla’s operating profit (EBIT adj.) increased by 8.7% to NOK 1,205 million in the second quarter of 2020. Operating revenues rose by 5.3% to NOK 11,099 million. Adjusted earnings per share increased in the quarter by 18% to NOK 1.10.Orkla’s Branded Consumer Goods operations, including Headquarters, had a 16% improvement in operating profit. The improvement is a result of factors including cost-cutting measures related to the coronavirus pandemic, productivity improvements and positive currency translation effects. Four out of five business areas had a marked improvement in operating

Instalco expands its heating & plumbing operations in Finland

Instalco has acquired Uudenmaan Lämpötekniikka Oy (ULT) in Helsinki, thereby expanding its heating & plumbing operations in Finland.The company has 46 employees and its sales for the 2018/2019 financial year were approximately SEK 75 million. This acquisition brings the total to 12 subsidiaries owned by Instalco in Finland, of which 6 offer heating & plumbing installations and 6 work with electrical installations. “ULT is a specialist company that fits nicely with the Instalco model and is a good match with our other subsidiaries in Finland. We expect that there will be many

Lantmännen’s harvest forecast: A normal harvest for 2020

Lantmännen forecasts that the annual harvest will amount to 6.1 million tons in total. The coronavirus pandemic has clearly shown how important Swedish agriculture and a functioning food chain are for Sweden’s ability to be self-sufficient, and the Swedish harvest is the basis for this.Lantmännen’s forecast for the annual harvest of grain, oilseed crops and pulses amounts to 6.1 million tons, which is lower than last year’s bumper harvest but slightly above the five-year average. “We are expecting a good harvest in Sweden this year, in terms of both volume and quality, although there

Read original

Early publication of Essity’s Half-year Report 2020

Essity’s Half-year Report for 2020 will be published on Monday, July 13 at approximately 7:00 a.m. CET instead of Friday, July 17 as previously communicated. The reason for the earlier publishing date is the uncertainty entailed by the ongoing COVID-19 pandemic. In conjunction with publication, a telephone and web presentation will be held on July 13 at 9:00 a.m. CET where President and CEO Magnus Groth will present the report and answer questions.Presentation:Date: Monday, July 13, 2020Time: 9:00 a.m. CETLink to web presentation: https://essity.videosync.fi/2020-07-13Telephone: +44

Scandion Oncology announces that the results of the 4 SCO-101 clinical phase I trials have been published in the journal “Basic & Clinical Pharmacology & Toxocology”.

Scandion Oncology A/S (“Scandion Oncology”) announces that the results from the 4 SCO-101 phase I clinical trials have been published in the International peer-reviewed journal” Basic & Clinical Pharmacology & Toxicology”.“An important part of drug development is to publish the results from the different development phases in order to allow a more detailed evaluation of the development. I am very happy that we can now present the data from the 4 clinical phase I studies that were performed by the former owner of SCO-101. As previously announced, SCO-101

There are no items matching the current filter
There are no more items matching the current filter
Back to top